FDA Inspection
LifeShare Blood CenterLifeShare Blood Center – FDA Inspection, Sep 1, 2022
Record Details
This FDA Inspection record concerns LifeShare Blood Center, with an inspection on September 1, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- LifeShare Blood Center
- Inspection Date
- September 1, 2022
- Product Type
- Biologics
View Company Profile
ID · d89ee1ee-4836-47b8-99d9-bc306a72b0c7
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1178705
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of LifeShare Blood Center
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 12, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for LifeShare Blood Center
- FDA Inspection 1248367 - 2024-07-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.